StockMarketWire.com - Numis today downgrades its investment rating on Hikma Pharmaceuticals PLC [LON:HIK] to add (from buy) and raised its price target to 1560p (from 1300p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk